Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory

Pharmacotherapy
Christina L AquilanteJulie A Johnson

Abstract

To compare the accuracy, speed, and cost of two methodologies used for genotyping known variants in the cytochrome P450 (CYP) 2C9 metabolizing enzyme gene. Comparative study. University research center. Fifteen-milliliter mouthwash samples collected from 253 subjects participating in a warfarin pharmacogenomic study. Genotyping for the isoleucine-to-leucine change at codon 359 (Ile359Leu [*3] polymorphism) was performed by using the Pyrosequencing and polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) methods in all 253 samples. Genotyping for the arginine-to-cysteine change at codon 144 (Arg144Cys [*2] polymorphism) was performed by using Pyrosequencing in all samples and by PCR-RFLP in a random subset of 136 samples. Comparisons of genotyping success rates, time efficiency, and cost analyses were conducted for Pyrosequencing and PCR-RFLP at each variant site. Pyrosequencing and PCR-RFLP produced similar success rates on the first genotyping attempt for the Arg144Cys variant (93.3% vs 90.4%, respectively) and the Ile359Leu variant (83.8% vs 79.1%, respectively). With Pyrosequencing, genotyping 96 samples for either polymorphism could be performed in 1 hour. In contrast, genotyping 96 samples by RFL...Continue Reading

References

Aug 1, 1996·Pharmacogenetics·T H Sullivan-KloseJ A Goldstein
Jan 28, 1999·Biochemical and Biophysical Research Communications·U YasarF Sjöqvist
Jan 13, 2001·Genome Research·M Ronaghi
Oct 27, 2001·British Journal of Clinical Pharmacology·J A Goldstein
Apr 23, 2002·British Journal of Clinical Pharmacology·Ann K DalyGuruprasad P Aithal
Apr 23, 2002·British Journal of Clinical Pharmacology·Joyce A Goldstein
Apr 23, 2002·Human Mutation·Hossein Fakhrai-RadMostafa Ronaghi
Aug 14, 2002·Pharmacotherapy·Tara Engeman AndrisinJulie A Johnson
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Feb 7, 2003·The New England Journal of Medicine·William E Evans, Howard L McLeod
May 15, 2003·The Pharmacogenomics Journal·X Chen, P F Sullivan
Sep 5, 2003·The New England Journal of Medicine·Alan E Guttmacher, Francis S Collins
Sep 27, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Ann K Daly
Oct 31, 2003·Trends in Genetics : TIG·Julie A Johnson
Apr 20, 2004·Assay and Drug Development Technologies·Solveig ErikssonAnders Alderborn

❮ Previous
Next ❯

Citations

Jun 11, 2008·European Journal of Clinical Pharmacology·G Oner OzgonJ A Johnson
Jul 26, 2008·Current Psychiatry Reports·Benedicto Crespo-FacorroIgnacio Mata
Apr 15, 2005·Mutation Research·Taimour Langaee, Mostafa Ronaghi
May 29, 2009·Genetic Testing and Molecular Biomarkers·Anzeela M SchentrupTaimour Y Langaee
Aug 30, 2008·Schizophrenia Bulletin·Maria J Arranz, Shitij Kapur
Jan 14, 2011·Pharmacogenetics and Genomics·Mohamed Hossam A ShahinJulie A Johnson
Feb 19, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Monica R McClainJames E Haddow
Mar 28, 2007·Blood·Eric A MillicanBrian F Gage
Apr 8, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Jose Luis RoyoAgustín Ruiz
Nov 8, 2005·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·Kewal K Jain
Apr 21, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Raffaele Di FranciaLuigi Formisano
Mar 30, 2005·Therapeutic Drug Monitoring·Sang Seop LeeJae-Gook Shin
Oct 31, 2009·Journal of Thrombosis and Haemostasis : JTH·N S FerderB F Gage
May 17, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Christina L AquilanteCourtney V Fletcher
Dec 17, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Wenndy HernandezMinoli A Perera
Nov 28, 2017·The Libyan Journal of Medicine·Yazun Bashir JarrarWassan Jarrar
Oct 24, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Christina L AquilanteTaimour Y Langaee
Feb 29, 2008·Clinical Pharmacology and Therapeutics·B F GageH L McLeod
Nov 26, 2004·Clinical Chemistry·Matthew W HruskaTaimour Y Langaee
Mar 1, 2005·Personalized Medicine·Ann K Daly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.